Skip to main content
Equibles

Nicholas Fernandez

Board Member

Liminatus Pharma, Inc. (LIMN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Liminatus Pharma, Inc. publishes a filing, an earnings call transcript or a press release.

Get LIMN alerts

About Nicholas Fernandez

Nicholas Fernandez is recorded as Board Member at Liminatus Pharma, Inc. (LIMN) since May 6, 2025. The newest filing on record that lists Nicholas Fernandez as Board Member at Liminatus Pharma, Inc. (LIMN) is dated July 13, 2026. Liminatus Pharma, Inc. reported in an 8-K filed May 6, 2025 that Nicholas Fernandez was appointed Company’s Board of Directors. Liminatus Pharma, Inc. reported in an 8-K filed May 6, 2025 that Nicholas Fernandez resigned as Iris’s board members. Liminatus Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Liminatus Pharma, Inc. includes Chris Kim (CEO and Board Member), Scott Dam (CFO), Beom K. Choi (CTO) and 4 others.

“Upon the consummation of the Business Combination, (i) the following Iris’s board members resigned in connection with the Business Combination: Rohit Nanani, Richard Peretz, Manish Shah and Nicholas Fernandez; and (ii) Chris Kim, Eun Sook Lee, Nicholas Fernandez and Ji Yeon Baek were appointed to the Company’s Board of Directors.”
Liminatus Pharma, Inc. Form 8-K, filed May 6, 2025 · Read the filing
“Upon the consummation of the Business Combination, (i) the following Iris’s board members resigned in connection with the Business Combination: Rohit Nanani, Richard Peretz, Manish Shah and Nicholas Fernandez; and (ii) Chris Kim, Eun Sook Lee, Nicholas Fernandez and Ji Yeon Baek were appointed to the Company’s Board of Directors.”
Liminatus Pharma, Inc. Form 8-K, filed May 6, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Liminatus Pharma, Inc.

Recent activity